US FDA partners Australia and Canada for cancer therapies review
The US Food and Drug Administration (FDA) has partnered with the Australian Therapeutic Goods Administration...
Read More...
Focus:
Australia
-
![Researchers develop genomic barcode to track immune cells]()
Researchers develop genomic barcode to track immune cells
A Garvan Institute of Medical Research team in Australia has created a genomic barcode to...
Read More...
-
![Cannabidiol uses]()
Study suggests CBD could be effective against microbial infections
Given the research is early-stage and has yet to be published, caution is advised, especially...
Read More...
-
![MND genetic mutations]()
Targeting MND-causing genetic mutations to support drug development
Motor neurone disease is a neurodegenerative condition with no cure and few treatment options to...
Read More...
-
![New discovery offers hope for global Strep A vaccine]()
New discovery offers hope for global Strep A vaccine
A team of international scientists have discovered common molecular targets across multiple strains of Group...
Read More...
-
![Australian court says GSK and Novartis misled consumers]()
GSK and Novartis misled consumers, says Federal Court of Australia
The Federal Court of Australia has said that subsidiaries of UK-based GlaxoSmithKline (GSK) and Swiss...
Read More...
-
![Janssen partners on inhalable therapy for postpartum haemorrhage]()
Inhalable oxytocin a potential treatment for postpartum haemorrhage
Inhalable oxytocin may be used in resource-limited states to manage postpartum haemorrhage, as the result...
Read More...
-
![peanut allergy]()
Aravax takes a step closer to developing a peanut allergy vaccine
PVX108 is a novel intradermal immunotherapy vaccine in a clinical trial for in peanut allergic...
Read More...
-
![SUDA, Zelda deal]()
SUDA and Zelda partner to develop medical grade cannabinoid spray
Australia-based SUDA Pharmaceuticals and Zelda Therapeutics have signed a feasibility and option agreement to develop...
Read More...
-
Deals this week: Mundipharma, Ligand Pharmaceuticals
Mundipharma has signed an agreement with Kolon Life Sciences to secure rights for osteoarthritis therapy...
Read More...